Bactobio (fka Baccuico), a London, UK-based biotechnology company discovering novel solutions from previously unculturable soil bacteria, closed a $3.8M seed funding round.
Backers included Peder Holk Nielsen (Former CEO & President, Novozymes), Leopoldo Zambeletti (Former Head of Healthcare, JP Morgan), Jonathan Milner (Founder, Abcam) and Claudio Costamagna (Former Chairman, Goldman Sachs, EMEA), and Hugh Grant (Former Chairman & CEO, Monsanto).
Proceeds from their latest round will accelerate the company’s vision through stepping up automation across the pipeline and adding key members to the team.
Led by Daniel Hansen, Founder and CEO, Bactobio has developed a platform to culture the 99% of soil bacteria and uncover valuable secondary metabolites they produce. Its proprietary technology combines microbiology with bioinformatics and machine learning to iteratively expand access to novel species with the potential to produce novel solutions across healthcare, agriculture and industrials markets.
FinSMEs
07/10/2021